Elanco Onsior 20 mg

Onsior is a prominent veterinary medication containing robenacoxib, designed for the treatment of pain and inflammation in dogs and cats. The brand was originally developed by the Swiss pharmaceutical giant Novartis within its Animal Health division.

In 2015, Elanco Animal Health, which was then a subsidiary of Eli Lilly and Company, acquired Novartis Animal Health, bringing Onsior into its portfolio. Elanco eventually spun off from Eli Lilly in 2019 to become an independent, publicly traded company. Manufacturing for Onsior primary active ingredients and tablet formulations typically occurs in Switzerland, maintaining the brand's European clinical origins. Today, Elanco stands as one of the world's largest animal health companies, providing innovative products for pets and livestock globally.